Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Ellis

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Pain Medicine (Malden, Mass.)|September 26, 2008
Source of drugs for prescription opioid analgesic abusers: a role for the Internet?Theodore J Cicero, Christopher Neil Shores, Alethea G Paradis, et al.
Journal of Substance Abuse Treatment|August 25, 2019
Gabapentin prescribed during substance abuse treatment: The perspective of treatment providersMance E Buttram, Steven P Kurtz, Matthew S Ellis, et al.
Pharmacoepidemiology and Drug Safety|November 10, 2018
Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivationMatthew S Ellis, Theodore J Cicero, Richard C Dart, et al.
JAMA Psychiatry|May 30, 2014
The changing face of heroin use in the United States: a retrospective analysis of the past 50 yearsTheodore J Cicero, Matthew S Ellis, Hilary L Surratt, et al.
Drug and Alcohol Dependence|July 3, 2014
Factors contributing to the rise of buprenorphine misuse: 2008-2013Theodore J Cicero, Matthew S Ellis, Hilary L Surratt, et al.
American Journal of Preventive Medicine|September 9, 2022
Associations of Transactional Sex and Sexually Transmitted Infections Among Treatment-Seeking Individuals With Opioid Use DisorderMatthew S Ellis, Zachary A Kasper, Bryce Takenaka, et al.
Journal of Opioid Management|September 4, 2025
Trends in XTAMPZA ER and other oxycodone misuse and abuse during COVID-19: A mosaic approachJennifer S Jewell, Kari M Rockhill, Hannah Burkett, et al.
Drug and Alcohol Dependence|March 12, 2025
People entering opioid substance use treatment have low rates of naloxone knowledge and possessionErin Bredenberg, Heather Olsen, Michael Ladka, et al.
JAMA Psychiatry|September 6, 2023
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use DisorderMatthew S Ellis, Kevin Y Xu, Vitor S Tardelli, et al.
Journal of Opioid Management|November 16, 2023
Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disordersS Geoff Severtson, Marie C Gurrola, Mark W Parrino, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Pain Medicine (Malden, Mass.)|September 26, 2008
Source of drugs for prescription opioid analgesic abusers: a role for the Internet?Theodore J Cicero, Christopher Neil Shores, Alethea G Paradis, et al.
Journal of Substance Abuse Treatment|August 25, 2019
Gabapentin prescribed during substance abuse treatment: The perspective of treatment providersMance E Buttram, Steven P Kurtz, Matthew S Ellis, et al.
Pharmacoepidemiology and Drug Safety|November 10, 2018
Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivationMatthew S Ellis, Theodore J Cicero, Richard C Dart, et al.
JAMA Psychiatry|May 30, 2014
The changing face of heroin use in the United States: a retrospective analysis of the past 50 yearsTheodore J Cicero, Matthew S Ellis, Hilary L Surratt, et al.
Drug and Alcohol Dependence|July 3, 2014
Factors contributing to the rise of buprenorphine misuse: 2008-2013Theodore J Cicero, Matthew S Ellis, Hilary L Surratt, et al.
American Journal of Preventive Medicine|September 9, 2022
Associations of Transactional Sex and Sexually Transmitted Infections Among Treatment-Seeking Individuals With Opioid Use DisorderMatthew S Ellis, Zachary A Kasper, Bryce Takenaka, et al.
Journal of Opioid Management|September 4, 2025
Trends in XTAMPZA ER and other oxycodone misuse and abuse during COVID-19: A mosaic approachJennifer S Jewell, Kari M Rockhill, Hannah Burkett, et al.
Drug and Alcohol Dependence|March 12, 2025
People entering opioid substance use treatment have low rates of naloxone knowledge and possessionErin Bredenberg, Heather Olsen, Michael Ladka, et al.
JAMA Psychiatry|September 6, 2023
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use DisorderMatthew S Ellis, Kevin Y Xu, Vitor S Tardelli, et al.
Journal of Opioid Management|November 16, 2023
Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disordersS Geoff Severtson, Marie C Gurrola, Mark W Parrino, et al.
Pageof 6